Agenus (AGEN) Exchange Rate Effect (2014 - 2026)
Agenus (AGEN) posted quarterly Exchange Rate Effect of -$11000.0 for Q1 2026, down 161.11% year-over-year from $18000.0 in Q1 2025, and down 375.0% quarter-over-quarter from $4000.0 in Q4 2025.
Analysis
Agenus (AGEN) Exchange Rate Effect (2014 - 2026) Analysis & Trends
Agenus' Exchange Rate Effect history runs 13 years deep, the most recent figure standing at -$11000.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 161.11% year-over-year to -$11000.0; the TTM figure through Mar 2026 stood at $18000.0 (up 115.0% YoY), while the FY2025 annual figure was $47000.0, up 118.08% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$11000.0, down from $4000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $391000.0 in Q2 2022, with the low at -$427000.0 in Q3 2022.
- The 5-year median for Exchange Rate Effect is -$20000.0 (2025), against an average of -$56235.3.
- Peak annual rise in Exchange Rate Effect reached 1065.22% in 2022, while the deepest fall reached 559.14% in 2022.
- Agenus' Exchange Rate Effect stood at $268000.0 in 2022, then slumped by 74.63% to $68000.0 in 2023, then plunged by 164.71% to -$44000.0 in 2024, then jumped by 109.09% to $4000.0 in 2025, then plunged by 375.0% to -$11000.0 in 2026.
- Business Quant data shows AGEN's Exchange Rate Effect at -$11000.0 in Q1 2026, $4000.0 in Q4 2025, and -$20000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -287,000.00 |
| 10 | Agenus | 343.11 Mn | 343.11 Mn | 34.52 Mn | -10,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10,000.00 |
| Mar 31, 2026 | -11,000.00 |
| Dec 31, 2025 | 4,000.00 |
| Sep 30, 2025 | -20,000.00 |
| Jun 30, 2025 | 45,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Dec 31, 2024 | -44,000.00 |
| Sep 30, 2024 | -260,000.00 |
| Jun 30, 2024 | 166,000.00 |
| Mar 31, 2024 | -122,000.00 |
| Dec 31, 2023 | 68,000.00 |
| Sep 30, 2023 | -255,000.00 |
| Jun 30, 2023 | -351,000.00 |
| Mar 31, 2023 | -90,000.00 |
| Dec 31, 2022 | 268,000.00 |
| Sep 30, 2022 | -427,000.00 |
| Jun 30, 2022 | 391,000.00 |
| Mar 31, 2022 | -336,000.00 |
| Dec 31, 2021 | 23,000.00 |
| Sep 30, 2021 | 93,000.00 |